medigraphic.com

2013, Number 1

<< Back Next >>

Rev Hosp Jua Mex 2013; 80 (1)

Tumor limítrofe de ovario coexistente con embarazo gemelar

Martínez-Jacinto Ó, Hernández AFJ, Benítez-Sánchez J, Meza-Caballero M, Corres-Molina M

Language: Spanish
References: 14
Page: 85-88
PDF size: 138.50 Kb.


ABSTRACT

The borderline ovarian tumor is a rare entity that is studied in the group of epithelial ovarian malignancies. Characterized by lack of stromal invasion, its prognosis is generally favorable. Borderline ovarian tumors are more common in women of reproductive age, while invasive epithelial malignancies are more common in postmenopausal women. Adnexal masses during pregnancy are found in only 1-4% of cases. Malignant ovarian tumors accompanying pregnancy are usually of epithelial histology, the most common presentation being borderline tumors. The objective of this paper is to present the case of a woman with a twin pregnancy and coexisting borderline ovarian tumor which was diagnosed and treated during pregnancy. We present a review of management and approach to adnexal mass during pregnancy.


REFERENCES

  1. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ (ed). Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer Verlag; 2002, p. 791.

  2. Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001; 75: 92.

  3. Ayhan A, Celik H, Taskiran C, et al. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer. Eur J Gynaecol Oncol 2003; 24: 223.

  4. Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 2002; 86: 34.

  5. Horowitz NS. Management of adnexal masses in pregnancy. Clin Obstet Gynecol 2011; 54(4): 519-27.

  6. Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS. Factors influencing the choice of laparoscopy or laparotomy in pregnant women with presumptive benign ovarian tumors. Int J Gynaecol Obstet 2010; 108(1): 12-5.

  7. Spitzer M, Kaushal N, Benjamin F. Maternal CA-125 levels in pregnancy and puerperium. J Reprod Med 1998; 43: 387-92.

  8. Berman JJ. Borderline Ovarian Tumor Workshop, Bethesda, Maryland, August 27-28, 2003. Hum Pathol 2004; 35(8): 907-9.

  9. Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, Copeland L, et al. Borderline Ovarian Tumors, Key Points and Workshop Summary. Human Pathology 2004; 35(8): 910-7.

  10. Giuntioli RL, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol 2006; 49: 492-505.

  11. Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, Oliva E, et al. Borderline ovarian tumors, contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Human Pathology 2004; 35(8): 918.

  12. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005; 123(Suppl.): S13-S57.

  13. Tropé CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 2012; 26(3): 325-36.

  14. National Comprehensive Cancer Network (NCCN) guidelines. Disponible en: www.nccn.org [Acceso 28 noviembre 2012].




2020     |     www.medigraphic.com